HEG Limited has scheduled a plant visit for analysts and institutional investors at its manufacturing facility in Mandideep, Madhya Pradesh. The visit is set to take place on Thursday, July 9, 2026, and is organized by 360 ONE Capital Market Private Limited. The interaction aims to provide stakeholders with an overview of the company's business operations and existing public domain information.

The scheduled event will include a tour of the company's plant facilities, specifically the Graphite Electrode facilities and the Anode Lab. The interaction is categorized as a pre-scheduled, closed-group plant visit and general management interaction. The company noted that the schedule remains subject to changes due to exigencies on the part of the investors or the company.

Management clarified that discussions during the visit will be general in nature. Senior management representatives participating in the interaction will not share, discuss, or disclose any Unpublished Price Sensitive Information (UPSI). The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Mandideep facility is located in District Raisen, near Bhopal. The company's registered office is also situated at the same location. HEG Limited is part of the Bhilwara Group and operates in the graphite electrode sector.

HEG Limited has scheduled its 54th Annual General Meeting (AGM) for Wednesday, July 29, 2026, at 12:00 Noon (IST) via Video Conferencing/Other Audio Visual Means (VC/OAVM). The meeting will be conducted without physical presence, with the registered office at Mandideep, Madhya Pradesh, deemed as the venue. The company has published the notice in newspapers including Business Standard and Nava Bharat, and the Annual Report for FY 2025-26 was dispatched on June 25, 2026.

Key AGM Dates and Shareholder Information

The following key dates are relevant for shareholders:

Businesses to Be Transacted

The agenda includes the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. The Board has recommended a final dividend of ₹3.40 per equity share of face value ₹2 each (170%) for FY 2025-26, subject to shareholder approval. The re-appointment of Shri Manish Gulati, Executive Director, who retires by rotation, is also on the agenda.

Special business items include the continuation of Shri Shekhar Agarwal as Non-Executive Non-Independent Director, who will attain the age of 75 years in FY 2027-2028, pursuant to Regulation 17(1A) of SEBI (LODR) Regulations, 2015. The ratification of remuneration payable to M/s. N.D. Birla & Co. as Cost Auditors for FY 2026-27 is also proposed.

E-Voting and Shareholder Instructions

Mr. Saket Sharma, a Practicing Company Secretary and Partner at M/s. GSK & Associates, has been appointed as the Scrutinizer for the e-voting process. Shareholders who have not registered their email IDs or bank details are requested to update them to ensure timely receipt of communications and to determine the appropriate Tax Deducted at Source (TDS) rate for dividend distribution. Documents for TDS determination must be submitted on or before July 13, 2026.